CBT
Cabot Corporation
MISCELLANEOUS CHEMICAL PRODUCTS
Cabot (CBT) Stock: Buy, Sell, or Hold?
$72.23
+0.04 (+0.06%)
▲
5d:
-3.82%
30d:
-4.29%
90d:
-16.27%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$72.65 – $75.64
Position: OVERSOLD
Forward P/E & Valuation
9.4x
CHEAP
vs 11.1x historical avg
Wall Street Target
$85.33
+18.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$70.36 / $76.51
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CBT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$119.91
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$74.46
3.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $72.23, which is considered oversold relative to its 30-day fair value range of $72.65 to $75.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.4) compared to its historical average (11.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This pessimistic expectation contrasts with the company's recent 58.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CBT is in a strong downtrend. The price is currently testing key support at $70.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $85.33 (+18.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBT is in a strong downtrend. The price is currently testing key support at $70.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $85.33 (+18.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$72.65 -
$75.64
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
Trading Range & Key Levels
30-Day Trading Range
$72.65 -
$75.64
Current vs Trading Range
OVERSOLD
Support Level
$70.36
Resistance Level
$76.51
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($85.33)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
9.37
Wall Street Target
$85.33
(+18.1%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
58.0%
Profit Margin
5.7%
Valuation Discount vs History
-5.4% cheaper
PE vs Historical
9.4 vs 11.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.4%
(market-implied from PE analysis)
1-Year Target
$68.33
(-5%)
2-Year Target
$64.64
(-11%)
3-Year Target
$61.15
(-15%)
3-Yr Target (if PE normalizes)
(PE: 9→11)
$72.45
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 10.0%)
$203.58
(+182%)
Base:
(SPY PE: 9.4, Growth: 10.0%)
$96.03
(+33%)
Bear:
(PE: 8.0, Growth: 10.0%)
$81.63
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 17.96 | Current EPS (TTM): $4.02
Bull Case
$152.30
(+111%)
Analyst growth 91.8%, PE expands to 19.8
Base Case
$138.45
(+92%)
Market implied 91.8%, PE stable at 18.0
Bear Case
$49.09
(-32%)
Severe decline -20.0%, PE contracts to 15.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.4 to 11.1
Stabilization Target:
$85.58
(+18.5%)
PE Expansion Potential:
+18.5%
Share CBT Analysis
Share this live CBT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CBT)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 2, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors on StockTwits express bullish sentiment towards $CBT, with some citing the company's strong earnings history and attractive valuation. No recent news articles were found.
Key Retail Themes:
strong earnings history
attractive valuation
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:51 AM ET
Data refreshes hourly during market hours. Next update: 3:51 AM
Data refreshes hourly during market hours. Next update: 3:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
STRONG BUY
29 analysts |
$551 | 40 SELL |
|
ECL
Ecolab Inc |
STRONG BUY
24 analysts |
$331 | 44 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
29 analysts |
$374 | 40 HOLD |
|
ALB
Albemarle Corp |
BUY
23 analysts |
$146 | 60 BUY |
|
APD
Air Products and Chemica… |
BUY
23 analysts |
$343 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CBT Research Pages
